Journal Logo

Poster Session II: Myeloma and other monoclonal gammopathies – Clinica

PS1407 TWICE WEEKLY CARFILZOMIB IS AN ACCEPTED TREATMENT BY PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY: INTERIM RESULTS OF THE CARO STUDY

Knauf, W.1; Ammon, A.2; Uhlig, J.3; Merling, M.4; Hurtz, H.-J.5; Riedt, T.6; Schulz, H.7; Vannier, C.8; Marschner, N.9; Potthoff, K.8

Author Information
doi: 10.1097/01.HS9.0000563904.96659.51
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.